QCM
JBIO

Quantinno Capital Management’s Jade Biosciences JBIO Stock Holding History

Quantinno Capital Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$429K Buy
30,551
+1,059
+4% +$15.3K ﹤0.01% 2825
2025
Q4 		$455K Buy
29,492
+2,517
+9% +$29.5K ﹤0.01% 2517
2025
Q3 		$233K Buy
26,975
+4,989
+23% +$40.8K ﹤0.01% 2649
2025
Q2 		$220K Buy
+21,986
New +$748K ﹤0.01% 2283

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Quantinno Capital Management's JBIO Position: Q1 2026 in Review

Quantinno Capital Management increased its Jade Biosciences (JBIO) stake by 3.6% in Q1 2026, buying an estimated $15.3K and bringing the position to 30,551 shares worth $429K. The position accounts for ﹤0.01% of the portfolio, ranked #2825.

Quantinno Capital Management first reported a position in JBIO in Q2 2025 and has held it in 4 quarters since. The position peaked at $455K in Q4 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Quantinno Capital Management held 30,551 shares of Jade Biosciences worth $429K as of Q1 2026.
  • Quantinno Capital Management bought 1,059 Jade Biosciences shares in Q1 2026, an estimated $15.3K.
  • Jade Biosciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2825 holding.
  • Quantinno Capital Management first reported a position in Jade Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Quantinno Capital Management's Jade Biosciences position peaked at $455K in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.